Our new drug could drastically change hemophilia patients' lives, BioMarin CEO says

In this video

Share

Our new drug could drastically change hemophilia patients' lives, BioMarin CEO says

Jim Cramer hears from BioMarin Chairman and CEO Jean-Jacques Bienaimé, who discusses new products in his company's pipeline.
05:36
Thu, May 10 20187:07 PM EDT